Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
Chen M, Li S, Huang M, Guo J, Huang X, Guo W, Chen L, Lin Y, Jacobs L, Wang C, Fu F. Chen M, et al. Among authors: guo j, guo w. Breast Cancer Res Treat. 2022 Nov;196(2):267-277. doi: 10.1007/s10549-022-06707-z. Epub 2022 Sep 13. Breast Cancer Res Treat. 2022. PMID: 36100784
Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients.
Li Y, Chen L, Lv J, Chen X, Zeng B, Chen M, Guo W, Lin Y, Yu L, Hou J, Li J, Zhou P, Zhang W, Li S, Jin X, Cai W, Zhang K, Huang Y, Wang C, Fu F. Li Y, et al. Among authors: guo w. BMC Cancer. 2022 Nov 2;22(1):1125. doi: 10.1186/s12885-022-10160-y. BMC Cancer. 2022. PMID: 36324133 Free PMC article.
Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F, Yu L, Zeng B, Chen M, Guo W, Chen L, Lin Y, Hou J, Li J, Li Y, Li S, Chen X, Zhang W, Jin X, Cai W, Zhang K, Chen H, Qiu Y, Nie Q, Wang C, Jacobs L. Fu F, et al. Among authors: guo w. JAMA Netw Open. 2022 Feb 1;5(2):e2145934. doi: 10.1001/jamanetworkopen.2021.45934. JAMA Netw Open. 2022. PMID: 35166783 Free PMC article.
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis.
Chen L, Wu F, Chen X, Chen Y, Deng L, Cai Q, Wu L, Guo W, Chen M, Li Y, Zhang W, Jin X, Chen H, Nie Q, Wu X, Lin Y, Wang C, Fu F. Chen L, et al. Among authors: guo w. NPJ Breast Cancer. 2023 May 31;9(1):46. doi: 10.1038/s41523-023-00552-z. NPJ Breast Cancer. 2023. PMID: 37258524 Free PMC article.
16,767 results
You have reached the last available page of results. Please see the User Guide for more information.